Esme Murphy,

Esme Murphy is a reporter and Sunday morning anchor for WCCO-TV. She has been with the station since 1990 and has won several awards for her reporting. She graduated from Harvard University and started her career in Tennessee before moving to Minnesota. She is married to David Klopp, the owner of a furniture store chain called Sofas and Chairs, whom she met while interviewing him for a story about the Cedar Lake Bicycle Trail.

53%

The Daily's Verdict

This author has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on the author's reporting.

Bias

50%

Examples:

  • The article suggests new hope for patients living with dementia and Alzheimer's disease, but only mentions a medication called Leqembi which slows down progression. The title is also misleading as it implies that the medication has been proven to work when in fact it is still under review by the FDA.

Conflicts of Interest

50%

Examples:

  • The article does not disclose any conflicts of interest related to Leqembi or its manufacturer. It would be helpful for the reader to know if the author or the station has any financial ties to the company that produces this medication.

Contradictions

100%

Examples:

  • The article contradicts itself by claiming that other medications that work like Leqembi can be and will become available in the future, but then saying they are still being reviewed by the FDA. This creates confusion for the reader about what is actually available and what is not.

Deceptions

50%

Examples:

  • The article is deceptive in its implication that Leqembi is a proven and effective treatment for dementia and Alzheimer's disease. It does not provide enough evidence or context to support this claim and leaves out important details about the medication's status with the FDA.

Recent Articles

Revolutionary Jab and Medication Show Promising Results in Preventing Alzheimer's Disease

Revolutionary Jab and Medication Show Promising Results in Preventing Alzheimer's Disease

Broke On: Sunday, 31 March 2024 A revolutionary jab and a medication called Leqembi are undergoing trials for Alzheimer's disease. The new vaccine aims to stop damage before it occurs, while the medication slows progression in early stages of dementia. Both have mild side effects and could be widely available within five years if successful in clinical trials.